There is no fee but advance registration is required.
Abstract: Strong communication is critical for the success of a toxicology program. Communicating effectively can keep your program on-track and help you establish long-lasting relationships with your clients and CRO partners. As members of a project development team, project toxicologists, study directors, and consultants work together to ensure a balanced assessment of the risk profile for drug candidates. Project toxicologists are responsible for conveying all project specific information to partnering study directors to ensure that studies conducted align with the development strategy and that the design and execution of studies are sufficient to support the assessment of safety of a drug. Consulting toxicologists may provide broad expertise in nonclinical safety assessment or serve as a subject matter expert; in either role, they need to be able to communicate pertinent information with the client and CRO. Study directors communicate about the project with internal (study team, management) and external (sponsor, other CROs, consultants) stakeholders and meet project deliverables and milestones. Specifically, the study director oversees various aspects of the project encompassing protocol development, in-life study management in collaboration with the CRO study team, and meeting project deliverables.
In this webinar, we will hear about best practices of communication throughout preclinical toxicology studies from the unique perspectives of a project toxicologist, consultant toxicologist, and study director.
Please listen-in to hear how these experienced toxicologists have worked to maintain efficient and timely communications and other lessons learned from their experience in the field.
Released: April 7, 2020 11:03 AM
| Updated: April 7, 2020 11:03 AM
We invite you and your colleagues to submit an abstract for presentation as a scientific poster. You have the option to opt-in to presenting a Rapid Fire Poster during the online submission, please be...
Copyright 2021 The Safety Pharmacology Society. All Rights Reserved.
All material, files, logos and trademarks within this site are properties of their respective organizations.